ISSN 2149-2263 | E-ISSN 2149-2271 Home      
 
Volume : 23 Issue : 1
Current Issue Archive Popular Article Ahead of Print

   
Quick Search





 
Epidemiological and Pharmacological Profile of Congestive Heart Failure at Turkish Academic Hospitals [Anatol J Cardiol]
Anatol J Cardiol. 2004; 4(1): 32-38

Epidemiological and Pharmacological Profile of Congestive Heart Failure at Turkish Academic Hospitals

Ali Ergin1, Namık Kemal Eryol2, Şükrü Ünal3, Abdullah Deliceo3, Ramazan Topsakal1, Ergun Seyfeli5
1Department of Cardiology, Erciyes University, School of Medicine, Kayseri, Turkey
2Department of Cardiology, School of Medicine, Erciyes University, Kayseri, Turkey
3Erciyes University Medical School, Department of Cardiology, Kayseri-Turkey
4Department of Cardiology, Erciyes University, School of Medicine, Kayseri, Turkey
5Department of Cardiology School of Medicine Mustafa Kemal University Antakya, Hatay, Turkey

Objective: We aimed to investigate the status of the treatment of congestive heart failure (CHF) in academic hospitals in Turkey. Methods: Overall 661 successive patients from 16 academic hospitals were included in this retrospective study. In addition to treatments given to the patients before admission to hospital, during their hospital stay, and at hospital discharge, data regarding their functional classifications, causes of CHF, and laboratory findings were also recorded. Results: In our study the mean age of patients was 61±12 years and the mean hospital stay 10±6 days. Ischemic CHF was observed more frequently in men (72%, 46%, p<0.001), while hypertension and rheumatic CHF were more frequent in women (27% vs 19%, p<0.001 and 24% vs 9%, p<0.001 respectively). While 90% patients’ were in NYHA III-IV class at admission to hospital, only 2% of patients were in class IV at hospital discharge. The proportion of smokers was greater in men than in women (68% vs. 12% ). Atrial fibrillation was present in 35% of patients. During hospitalization, angiotensin converting enzyme (ACE) inhibitors were used by 77%, diuretics by 95%, digitalis by 76%, nitrate by 85%, beta-blockers by 3 %, aspirin by 86%, anticoagulants by 44%, Ca antagonist by 10%, positive inotropic agents by 42%; and antiarrhythmic agents by 15% of patients. Conclusion: The use of ACE inhibitors, the major milestone of CHF treatment, is not on an adequate level yet. The use of beta blockers should also be encouraged.

Keywords: Epidemiology, heart failure, Turkish academic hospitals


Türk Eğitim Hastanelerinde Konjestif Kalp Yetersizliğinin Epidemiyolojik ve Farmakolojik Profili

Ali Ergin1, Namık Kemal Eryol2, Şükrü Ünal3, Abdullah Deliceo3, Ramazan Topsakal1, Ergun Seyfeli5
1Department of Cardiology, Erciyes University, School of Medicine, Kayseri, Turkey
2Department of Cardiology, School of Medicine, Erciyes University, Kayseri, Turkey
3Erciyes University Medical School, Department of Cardiology, Kayseri-Turkey
4Department of Cardiology, Erciyes University, School of Medicine, Kayseri, Turkey
5Department of Cardiology School of Medicine Mustafa Kemal University Antakya, Hatay, Turkey

Anahtar Kelimeler: Epidemiyoloji, kalp yetersizliği, Türkiye’de üniversite hastaneleri


Ali Ergin, Namık Kemal Eryol, Şükrü Ünal, Abdullah Deliceo, Ramazan Topsakal, Ergun Seyfeli. Epidemiological and Pharmacological Profile of Congestive Heart Failure at Turkish Academic Hospitals. Anatol J Cardiol. 2004; 4(1): 32-38


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share


Similar articles
PubMed
Google Scholar




 
 
KARE Publishing | Copyright © 2018 Turkish Society of Cardiology